FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug Aduhelm

Robert Calif acknowledged that the agency made mistakes when it failed to properly document interactions with…

New Alzheimer’s Drug Approved by FDA, Promises to Slow Disease

Health Eisai and Biogen’s Leqembi is the first drug to show that reducing a protein linked…

Pharma has a hiding place during recession

As pharma companies begin reporting earnings next week, investors could be forgiven for paying more attention…

The supply of effective COVID antibody drug in the US is dwindling

Federal government stores of a key COVID-19 antibody drug, a key weapon to keep the infected…